VAGINAL NEOPLASMS

Clinical trials for VAGINAL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new VAGINAL NEOPLASMS trials appear

Sign up with your email to follow new studies for VAGINAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare cancers: immunotherapy drug targets tumors regardless of origin

Disease control Recruiting now

This study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…

Matched conditions: VAGINAL NEOPLASMS

Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

VAGINAL NEOPLASMS

Get alerted when new VAGINAL NEOPLASMS trials appear

New hope for rare cancers: immunotherapy drug targets tumors regardless of origin